KCNE4 Inhibitors

Chemical inhibitors of KCNE4 operate by targeting the potassium channels that are modulated by the protein, leading to a decrease in potassium ion conductance across the cell membrane. Chromanol 293B, for instance, binds directly to the KCNE4-associated potassium channels, which include the complexes formed with KCNQ1, and inhibits their activity. This blockade results in a reduced ability for potassium to flow through these channels, thus inhibiting the functional activity of KCNE4. Similarly, HMR-1556 is selective for KCNQ1/KCNE4 channels, and it impedes the potassium current by altering the gating mechanism of the channel, directly reducing KCNE4 channel activity. JNJ303, another potent blocker, accomplishes inhibition by stabilizing the closed state of the KCNQ1/KCNE4 channels, effectively reducing the ion conductance facilitated by KCNE4.

Furthermore, Linopirdine and XE991 are selective blockers of the KV7/KCNQ family of potassium channels, which KCNE4 can modulate. Linopirdine decreases KCNE4's influence on the membrane potential by reducing the probability of the channel being in an open state, while XE991 inhibits channel activity by binding to the open channel configuration, preventing potassium flux. Correolide, a natural product, also blocks potassium channels by binding to the channel pore, thereby inhibiting the ion conductance and the function of KCNE4. L-768673 modifies the activation and inactivation kinetics of KCNQ1/KCNE4 channels, leading to a diminished KCNE4-mediated potassium current. Retigabine, at high concentrations, can non-selectively inhibit potassium channels including those associated with KCNE4 by modifying the voltage-sensing domain of the channel. Clofilium, Dofetilide, Azimilide, and E-4031 are all blockers of specific potassium channel currents that KCNE4 is known to regulate. Clofilium interferes with the pore domain of the channel, Dofetilide and E-4031 selectively inhibit the rapid component of the delayed rectifier potassium current, and Azimilide blocks both the rapid (Ikr) and slow (Iks) components of the cardiac potassium channels, which include KCNE4 complexes, thereby inhibiting the repolarizing current that KCNE4 helps to regulate. Each of these chemicals, by interacting with the channel's different domains or by altering channel kinetics, effectively reduces KCNE4's role in potassium ion conductance.